Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECIGEN, INC.XON · Entity 4356 | SVP, Energy & Fine Chem. | June 30, 2019 | July 02, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECIGEN, INC.
Report date June 30, 2019 · Filed July 02, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,816 |
Ending reported balance
After 2019-07-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-06-30 · Exercise / conversion · Acquired 14,341 · Balance 33,823 F1: Each restricted stock unit represents a contingent right to receive one share of XON common stock. Row 2 · 2019-07-01 · Sale · Disposed 5,007 · Balance 28,816 F2: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 43,021 |
Reported balance
After 2019-06-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-06-30 · Exercise / conversion · Disposed 14,341 · Balance 43,021 F1: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3: The restricted stock units were granted on April 9, 2019, and the remaining restricted stock units vest in three equal quarterly installments on each of September 30, 2019, December 31, 2019 and March 31, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of XON common stock.
F2: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
F3: The restricted stock units were granted on April 9, 2019, and the remaining restricted stock units vest in three equal quarterly installments on each of September 30, 2019, December 31, 2019 and March 31, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2019 Filed Jul 2, 2019 23:13 UTC | PRECIGEN, INC. XON · Entity 4356 | SaleCommon Stock | 5,007 | $7.76 | $38,854.32 |
DisclosureSEC source: 0001123292-19-000966 · edgar.xml · nonDerivative · entry 2 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,816 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 23:13 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 14,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000966 · edgar.xml · derivative · entry 3 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,021 Underlying: Common Stock · 14,341 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units were granted on April 9, 2019, and the remaining restricted stock units vest in three equal quarterly installments on each of September 30, 2019, December 31, 2019 and March 31, 2020. F3 · derivative.expiration_date: The restricted stock units were granted on April 9, 2019, and the remaining restricted stock units vest in three equal quarterly installments on each of September 30, 2019, December 31, 2019 and March 31, 2020. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 23:13 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionCommon Stock | 14,341 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000966 · edgar.xml · nonDerivative · entry 1 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. Read SEC document |
| April 09, 2019 Filed Apr 12, 2019 01:42 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantRestricted Stock Units · Derivative | 57,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000629 · edgar.xml · derivative · entry 1 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,362 Underlying: Common Stock · 57,362 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F2 · derivative.exercise_date: The restricted stock units vest in four equal quarterly installments beginning June 30, 2019. F2 · derivative.expiration_date: The restricted stock units vest in four equal quarterly installments beginning June 30, 2019. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:05 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantRestricted Stock Units · Derivative | 75,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000126 · edgar.xml · derivative · entry 2 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,758 Underlying: Common Stock · 75,758 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:05 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000126 · edgar.xml · nonDerivative · entry 1 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,482 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 04, 2019 Filed Jan 22, 2019 23:07 UTC Amendment | PRECIGEN, INC. XON · Entity 4356 | GrantRestricted Stock Units · Derivative | 75,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000184 · edgar.xml · derivative · entry 2 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,758 Underlying: Common Stock · 75,758 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · shares: The number of derivative securities acquired was incorrectly reported as being disposed of in the report filed January 8, 2019. F4 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F4 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 22, 2019 23:07 UTC Amendment | PRECIGEN, INC. XON · Entity 4356 | GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000184 · edgar.xml · nonDerivative · entry 1 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,482 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 23:46 UTC | PRECIGEN, INC. XON · Entity 4356 | SaleCommon Stock | 4,058 | $7.07 | $28,691.68 |
DisclosureSEC source: 0001123292-19-000082 · edgar.xml · nonDerivative · entry 2 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,708 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:46 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 9,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000082 · edgar.xml · derivative · entry 3 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,297 Underlying: Common Stock · 9,766 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in three equal annual installments on each of January 2, 2020, 2021 and 2022. F3 · derivative.expiration_date: The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in three equal annual installments on each of January 2, 2020, 2021 and 2022. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:46 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionCommon Stock | 9,766 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000082 · edgar.xml · nonDerivative · entry 1 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. Read SEC document |
| January 02, 2018 Filed Jan 9, 2018 01:22 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantRestricted Stock Units · Derivative | 39,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-18-000107 · edgar.xml · derivative · entry 1 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,063 Underlying: Common Stock · 39,063 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 2, 2019. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 2, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.